Jonathan
Analyst
Analyst — Needham
Earnings-call appearances
-
Taysha Gene Therapies Second Quarter 2026 Financial Results Conference Call2026-08-11
Taysha Gene Therapies, Inc. (TSHA)
-
REVTORPYK FDA Approval Conference Call2026-07-14
Celcuity Inc. (CELC)